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Background: Chinese biomedical databases contain a large number of publications available to systematic
reviewers, but it is unclear whether they are used for synthesizing the available evidence.
Methods: We report a case of two systematic reviews on the accuracy of anti-cyclic citrullinated peptide for
diagnosing rheumatoid arthritis. In one of these, the authors did not search Chinese databases; in the other,
they did. We additionally assessed the extent to which Cochrane reviewers have searched Chinese databases in
a systematic overview of the Cochrane Library (inception to 2014).
Results: The two diagnostic reviews included a total of 269 unique studies, but only 4 studies were included
in both reviews. The first review included five studies published in the Chinese language (out of 151) while the
second included 114 (out of 118). The summary accuracy estimates from the two reviews were comparable.
Only 243 of the published 8,680 Cochrane reviews (less than 3%) searched one or more of the five major
Chinese databases. These Chinese databases index about 2,500 journals, of which less than 6% are also indexed
in MEDLINE. All 243 Cochrane reviews evaluated an intervention, 179 (74%) had at least one author with a
Chinese affiliation; 118 (49%) addressed a topic in complementary or alternative medicine.
Discussion and conclusions: Although searching Chinese databases may lead to the identification of a large
amount of additional clinical evidence, Cochrane reviewers have rarely included them in their search strategy.
We encourage future initiatives to evaluate more systematically the relevance of searching Chinese databases,
as well as collaborative efforts to allow better incorporation of Chinese resources in systematic reviews.
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DatabasesBackground
Systematic reviews are a cornerstone of evidence-based
medicine. Developing a comprehensive literature search
is a key element in retrieving all relevant evidence avail-
able to answer a specific clinical question. Since it was
shown that trials with significant results are more likely
to be published in English-language journals [1], stan-
dards from the Cochrane Collaboration recommend that
‘whenever possible review authors should attempt to
identify and assess for eligibility all possibly relevant* Correspondence: j.f.cohen@amc.uva.nl
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[2]. Including studies published in languages other than
English not only prevents from language bias but also
increases precision of meta-analysis estimates and statis-
tical power to explore sources of heterogeneity.
Several empirical studies have evaluated the influence
of English language restrictions in systematic reviews
and meta-analyses of treatment effects [3]. A systematic
review of those studies found no evidence of bias when
restricting to English language literature in reviews of
conventional medical interventions [3]. A similar evalu-
ation in the field of complementary and alternative
medicine found that English-language studies tend to re-
port smaller effects than those published in other lan-
guages [4].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ously growing over the past decades. China’s share in the
world’s total published scientific papers increased from
less than 1% in 1980 to about 12% in 2011, currently
ranking second behind the US [5]. There is limited evi-
dence that searching Chinese databases when perform-
ing systematic reviews leads to the identification of
additional relevant studies and influences the outcome
of meta-analysis. Available studies are limited to the field
of traditional Chinese medicine, and the results of such
investigations have been conflicting [6-8].
We here report on a case of two recently published in-
dependent systematic reviews on the same topic: one for
which the authors did not search in Chinese databases
and the other for which the authors did. We describe
five major Chinese electronic biomedical literature data-
bases, with regard to content, search features, and acces-
sibility. We also evaluate to what extent Cochrane




In an ongoing meta-epidemiological project about methods
used in systematic reviews of diagnostic accuracy studies
[9,10], we identified a systematic review on the accuracy of
anti-cyclic citrullinated peptide (anti-CCP) antibodies forTable 1 Comparison of Whiting et al.’s and Gao et al.’s system
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a151 studies corresponding to 155 publications were included; bEstimates from case-co
interval; CNKI, China National Knowledge Infrastructure.diagnosing rheumatoid arthritis [11]. We were also aware
of another systematic review on the same topic in which
former members of our research group participated [12].
In both reviews, the 1987 revised American College of
Rheumatology criteria served as the clinical reference
standard [11,12]. A detailed description of the reviews can
be found in Table 1. Both reviews covered the same topic
and showed overlap in their timeframe of interest. We
additionally identified two earlier systematic reviews on
the same topic, but they could not be compared with the
others because of different timeframes for the literature
search [13,14].
In contrast with the review of Whiting et al., the review
from Gao et al. specifically aimed to evaluate the accuracy
of anti-CCP antibodies in the Chinese population. The ra-
tionale for restricting the review to the Chinese population
was a presumed variability in anti-CCP accuracy, related
to the genetic or ethnic background. Gao et al. only
searched for studies reported in English or Chinese,
whereas the review fromWhiting et al. had no geographical
or language restrictions.
The most striking finding when comparing the two re-
views is the large number of studies published in the
Chinese language identified by Gao et al. but not by
Whiting et al. Gao and colleagues searched two biomed-
ical databases (MEDLINE and China National Knowledge
Infrastructure (CNKI), 2000 to 2010) and included 118atic reviews
Gao et al. 2012 [11]
eumatoid
th early
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ntrol studies (n = 97). Anti-CCP, anti-cyclic citrullinated peptide; CI, confidence
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ese language. Although Whiting and her colleagues
thoroughly searched 10 databases (inception to 2009)
without language restrictions and were able to include
151 studies (155 publications), only 5 of these were re-
ported in the Chinese language. In total, the two re-
views identified 269 unique studies. Surprisingly, only
four primary studies can be found in both reviews (Figure 1).
This discrepancy can be explained by the fact that Gao et
al. also searched CNKI, one of the largest Chinese biomed-
ical databases, while Whiting et al. did not.
The summary estimates of test accuracy generated by
the two meta-analyses were comparable. Gao et al. re-
ported a summary estimate of sensitivity of 65% (95%
confidence interval (CI) 65% to 66%) at a specificity of
95% (95% to 96%). Most studies in this review had used
multiple sets of patient inclusion criteria. Whiting et al.
analyzed a subset of case-control studies in their review
(n = 97) and reported summary estimates of 68% (65%
to 71%) for sensitivity and 95% (94% to 96%) for
specificity.
A limitation when trying to compare the two anti-CCP
reviews lies in the lack of details about the index tests
under investigation in Gao’s review. Whiting et al. pro-
vided a complete description of the different types of
anti-CCP antibodies evaluated across primary studies
(antifilaggrin antibodies; antikeratin antibodies; antiperi-
nuclear factor; first, second, or third generation anti-
CCP; mutated citrullinated vimentin) whereas Gao et al.
only characterized assays by manufacturer (Eurimmun
vs. non-Eurimmun tests). Yet the fact that the summary
accuracy estimates are almost identical in both reviews
suggests that the same kind of index tests were
reviewed.
In this case, a very large body of evidence (114 studies)
was missed through not searching in a Chinese database,
but this additional evidence seemed to be of noFigure 1 Number of studies included by each review and
corresponding overlap.influence on summary accuracy estimates. Here, the
results were similar and it may therefore be un-
necessary to search Chinese databases, but no claim
is made that this would apply to all cases. It is
largely unknown whether Chinese databases contain
relevant clinical data for systematic reviews and
whether including this data would affect the out-
comes and conclusions. Further research is needed
to resolve this question, especially in fields other
than complementary and alternative medicine. Wu et
al. previously reported on a case of two independent
reviews evaluating the effectiveness of acupuncture
for chronic asthma [8]. While the first review only
searched English language databases, the other also
searched Chinese databases. This strategy almost
doubled the number of included trials (12 vs. 22)
and led to an almost ninefold increase in the num-
ber of included patients (350 vs. 3,058). The review
that searched in Chinese databases found a signifi-
cant effect of acupuncture on spirometry parameters
whereas the other review found no evidence favoring
acupuncture. It is highly likely that the amount of
data in Chinese databases and their effect on the
summary estimates differ by topic of interest and
across study types (for example, interventions, diag-
nostic test accuracy, and prognostic and omics
marker evaluations).Chinese biomedical databases
Xia et al. have extensively described five major biomedical
databases originating from China: CNKI, Chinese Biomed-
ical Literature (CBM), Chinese Medical Current Content
(CMCC), VIP, and WANFANG (China Online Journals)
[15]. They reported that less than 6% of the 2,500 journals
indexed in these databases were also indexed in MED-
LINE. All databases had advanced search features that
allowed combining keywords with Boolean and proximity
operators. Four databases had even more advanced search
features that allowed command-line-style queries with
keywords, fields, Boolean, and proximity operators. All da-
tabases accepted English-written queries but all were also
language sensitive. In terms of accessibility, all databases
but CBM gave free access to study abstracts and offered
the possibility to purchase full-text articles without full
subscription to the database. CBM search features were
accessible to subscribers only. In another recent evaluation
of the relevance of searching Chinese biomedical data-
bases (CBM, CNKI, VIP, and WANFANG) when conduct-
ing systematic reviews, Ai et al. found that CBM and
CNKI were the two databases that covered the most jour-
nals (1,784 and 1,126, respectively) [16]. The authors rec-
ommended CBM for reviewers who aim to search for
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researchers.Searching Chinese databases: current practice
among Cochrane reviewers
The Cochrane Collaboration recommends searching
without language restrictions to avoid language bias.
It also suggests searching regional databases when
relevant, citing CBM as an example of a Chinese
database [2]. We aimed to evaluate whether authors
of published Cochrane reviews had searched Chinese
databases.
Study selection was performed by searching the full
text of Cochrane reviews for any reference to at least
one of the five major Chinese databases. On October 8,
2014, we searched the Cochrane Library from inception
using full text screening for the words ‘China National
Knowledge Infrastructure’, ‘China Academic Journals’
(former name of CNKI), ‘cnki’, ‘Chinese Biomedical Lit-
erature Database’, ‘cbm’, ‘Chinese Medical Current Con-
tent’, ‘cmcc’, ‘VIP’, ‘Wanfang’, or ‘Wan fang’. Protocols
were excluded. Data extraction was performed by one
author (JFC or DAK) using a standardized form. We ex-
tracted the name of the first author and publication year,
whether the reviewers had applied any language restric-
tions, which of the five Chinese databases were searched,
and whether any review author had a Chinese affiliation.
We also extracted whether the review addressed a com-
plementary or alternative medicine topic (as defined by
Kemper et al.) [17].
Among 8,680 published reviews indexed in the
Cochrane Library, only 243 (3%) had searched at least
one of the five major Chinese databases. These were
retained for further analysis. All included Cochrane
reviews evaluated an intervention, 179 (74%) had at
least one author with a Chinese affiliation and 118
(49%) addressed a topic in complementary or alterna-
tive medicine. About half of reviewers had searched
multiple Chinese databases (135, 56%). CNKI and
CBM were most frequently searched (in 185 [76%]
and 162 [67%] cases, respectively) while CMCC was
searched in only 21 cases (9%). The great majority of
the reviews, 213 (88%), explicitly declared not to have
applied any language restrictions, compared to one re-
view that did, while 29 reviews did not make any
statement on language restrictions.
A limitation to this study is that we only investigated
Cochrane systematic reviews, which may stand apart
from other reviews because of high standards for the
conduct and reporting of literature search. A comparable
evaluation of search strategies used in 235 systematic re-
views of diagnostic test accuracy published in China be-
fore 2011 found that Chinese reviewers had searchedChinese databases (with or without English language da-
tabases) in 205 (87%) cases [18].
Discussion
Our case report highlights that large numbers of publi-
cations may be missed when not searching Chinese data-
bases. In a systematic literature survey, we found that
Cochrane reviewers searching Chinese databases are an
exception, mainly limited to review teams with an author
with a Chinese affiliation, and focusing on interventions
in complementary or alternative medicine.
A major hurdle to searching Chinese databases is the
amount of resources and personnel needed. Systematic
review projects often suffer from time and budget con-
straints, which may conflict with authors’ willingness to
maximize the amount of evidence relevant to their clin-
ical question. Searching Chinese databases and extract-
ing data from large amounts of Chinese publications
implies having at least one Chinese language reviewer
on board or resources to work with biomedical-oriented
professional translators. Balk et al. found that Google
Translate may be helpful in extracting data from non-
English literature (Chinese, French, German, Japanese,
and Spanish) [19]. Unfortunately, Chinese translations
provided the least accurate data in this comparison, with
about one out of five items incorrectly extracted more
than half of the times when using Google Translate, as
compared to extraction performed by a fluent speaker.
The credibility and integrity of the studies that can be
additionally included when searching Chinese databases
should also be taken into account. We are not aware of
any direct way to evaluate the reliability of the data con-
tained in biomedical journals and databases. One can
only evaluate indirect evidence, such as evidence of sci-
entific misconduct. A number of cases of scientific fraud
and misconduct in China have been reported in the past
few years, including plagiarism, falsification, and fabrica-
tion of data [20]. This has led to growing concern that
those Chinese scandals are only the emerged tip of the
iceberg. Chinese scientific authorities and universities
seem to have recognized the problem and have increas-
ingly been developing efforts and implementing active
policies against research misconduct [21,22]. The issue
of research integrity extends far beyond China: a system-
atic evaluation of all 788 English language research arti-
cles retracted from PubMed between 2000 and 2010
found that among all retractions, 33% and 11% origi-
nated from the USA and China, respectively [23].
Conclusions
If we want to include all available evidence in systematic
reviews, we need to develop strategies to take into ac-
count the huge share of biomedical research published
by scientists who write in their native language rather
Cohen et al. Systematic Reviews  (2015) 4:23 Page 5 of 5than in English. Otherwise, such valuable information
might remain unused by English-speaking evidence-based
practitioners and researchers. We advocate that Chinese
biomedical research should be more accessible and trans-
parent, to allow better identification of studies published
in Chinese. We also suggest to strengthen relationships
and collaborative efforts between Chinese-speaking bio-
medical researchers and non-Chinese-speaking groups,
to facilitate the inclusion of Chinese data in systematic
reviews when relevant.
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